12:00 AM
Feb 25, 2013
 |  BC Week In Review  |  Company News  |  Other News

Novartis pharmaceuticals news

Novartis said its board and Daniel Vasella, who departed last week as chairman, agreed to forgo a non-compete agreement and all related compensation. Under the non-compete, Novartis would have paid Vasella up to CHF12 million ($13 million) annually for six years on...

Read the full 186 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >